Status:
COMPLETED
The Moment Study: Mixed Method E-cigarette Study
Lead Sponsor:
Truth Initiative
Conditions:
Smoking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The universe of tobacco products is expanding, with new noncombustible products gaining popularity even as the reduction in prevalence of cigarette smoking slows or stalls. E-cigarettes, or Electronic...
Eligibility Criteria
Inclusion
- Participants must:
- be aged 18 years or older
- reside in Washington, D.C. metro area (including VA and MD suburbs)
- be proficient in English
- be daily smoker with at least 5 years of established daily smoking
- A person will be categorized as a daily smoker if he reports daily smoking of at least 8 cigarettes a day for the past 5 years, and records an exhaled air carbon monoxide (CO) level \> 8 parts-per-million (ppm) at the baseline in-person meeting.
- Daily smokers will be eligible for the main study if they do not intend to quit in the next 30 days.
- If they do intend to quit in the next 30 days, eligible daily smokers will be enrolled in the second arm of the study.
- not taking smoking cessation medications;
- smoked LCC/cigars/hookah less than 5 times in last 30 days
- have not used other tobacco products in last 30 days
- have not used an ENDS product (electronic cigarette) in the last 30 days
- be interested in trying an ENDS
- have an iPhone or Android that allows installation of applications and use it daily
- have a phone plan that allows unlimited text messages
- be willing to travel to the data collection cite four times in three weeks
- not be breastfeeding or planning to become pregnant
- not have heart disease/uncontrolled blood pressure
- not have psychosis/suicidal thoughts
- not be currently enrolled in an alcohol treatment program
- not be out of town for more than 5 nights in the next 6 weeks
Exclusion
- Individuals who do not satisfy the criteria above will not be eligible for this study.
- There will be no involvement of vulnerable populations.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT02261363
Start Date
August 1 2014
End Date
August 1 2016
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American Legacy Foundation
Washington D.C., District of Columbia, United States, 20036